Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
  1. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $21.13 ($95,097)
  2. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $18.97 ($85,369)
  3. 4 Open-market sale President and CEO sold 15,714 shares at an average $18.55 ($291,474)
  4. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $22.97 ($103,350)
  5. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $21.21 ($95,464)
  6. 4 Open-market sale President and CEO sold 15,714 shares at $21.63 ($339,829)
  7. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $21.51 ($96,791)
  8. 4/A Grant or award Director acquired 55,555 shares (grant or award)
  9. 4 Open-market buy Director bought 55,555 shares at $18.00 ($999,990)
  10. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $22.32 ($100,439)
  11. 4 Open-market sale President and CEO sold 15,714 shares at $22.45 ($352,833)
  12. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $22.80 ($102,587)
  13. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $19.96 ($89,829)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion VP Finance & Operations acquired 3,481 shares (option exercise)
  20. 4 Open-market sale President and CEO sold 3,839 shares at $18.57 ($71,276)

Page 15 of 18 · 354 filings